Education and support program for rare disease kids
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study tests a targeted educational and support program for children and teens with rare diseases. It helps families learn more about the condition and cope better with day-to-day challenges.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child has a confirmed rare disease diagnosis.
- Age 5 to 20 years old (with developmental age between 5 and 18).
- You are already getting medical care for the rare disease at a participating study center.
- You can fill out questionnaires and take part in the educational sessions (psychoeducation).
- Your child does not have moderate or severe cognitive delays, is not in intensive psychotherapy, and can attend all appointments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial gathers feedback from rare disease patients or those suspected of having a rare disease. The goal is to create a more flexible consent process for future research.
This study tests a targeted approach to help teenagers with inherited metabolism conditions successfully transfer from children’s to adult healthcare. It may help families feel more confident and reduce problems during the handoff to adult services.
This study asks children with rare diseases and their families about what kind of palliative care (comfort and support) they need. It aims to understand how to better help families through their child's illness.
This study looks at how young adults aged 15–25 with rare genetic conditions (like certain bone, skin, hearing, or facial conditions) are doing in school, work, and social life. Researchers want to understand what helps or prevents young people with these conditions from being included in their communities.
This study aims to understand the perspectives of parents, caregivers, family members, and professionals involved with children who have ultra-rare genetic disorders. It uses interviews or focus groups to explore ethical and value-based questions.
This study looks at how families adapt and how relationships change over time when a child has a rare disease. It involves both the child and their parents completing questionnaires and possibly a smartphone app for a few days.
Hear when a new Orphan Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.